Bayer said first-quarter sales and net income fell on negative foreign currency exchange rates and the global drug company cut its full-year revenue forecast to below last year’s sales of 35 billion euros ($42 billion).
Germany-based Bayer said first-quarter sales were 9.1 billion euros, down 5.6 percent from a year ago. Adjusted for the currency effects, sales rose 2 percent.
Net income fell 6 percent to 1.96 billion euros.
Negative effects of the exchange rate totaled about 160 million euros, Bayer said.
The company has about 1,600 employees in the Pittsburgh region including 600 in administrative jobs and 1,000 at a health care unit.
The company expects to close on its $66 billion acquisition of U.S. agricultural seeds maker Monsanto by the end of the second quarter.
The European Commission has given conditional approval to the deal which awaits clearance by the U.S. Federal Trade Commission.
Joyce Gannon: jgannon@post-gazette.com or 412-263-1580.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.